Quantification and characterization of total cellular p53 protein in colorectal cancer

Cytometry

Volumn 31, Issue 1, 1998, Pages 60-66

  Tominaga, Osamu ^a,c   Hammel, Pascal ^b   Hamelin, Richard ^a   Nagawa, Hirokazu ^c   Muto, Tetsuichiro ^c   Remvikos, Yorghos ^a  

^a INSTITUT CURIE   (France)

^b BEAUJON HOSPITAL   (France)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Colorectal cancer; Enzyme linked immunoabsorbent assay; Flow cytometry; p53 mutation; p53 protein

Indexed keywords

DNA; PROTEIN P53;

ARTICLE; COLORECTAL CANCER; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ASSAY;

ADENOMA; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; MUTATION; NEOPLASM PROTEINS; PHENOTYPE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031985519     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19980101)31:1<60::AID-CYTO8>3.0.CO;2-N     Document Type: Article

References (28)

1. Barnes DM, Hanby AM, Gillett CE, Mohammed S, Hodgson S, Bobrow LG, Leigh IM, Purkis T, MacGeoch C, Spurr NK, Bartek J, Vojtesek B, Picksley SM, Laure DP: Abnormal expression of wild type p53 protein in normal cells of a cancer family patient. Lancet 340:259-263, 1992.
2. Bodner SM, Minna JD, Jensen SM, D'Amico D, Carbone D, Mitsudomi T, Fedorko J, Buchhagen DL, Nau MM, Gazdar AF: Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene 7:743-749, 1992.
3. Bosari S, Viale G, Roncalli M, Graziani D, Borsani G, Lee AK, Coggi G: p53 gene mutations, p53 protein accumulation and conpartmentalization in colorectal adenocarcinoma. Am J Pathol 147:790-798, 1995.
4. Carder P, Wyllie AH, Purdie CA, Morris RG, White S, Piris J, Bird CC: Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene 8:1397-1401, 1993.
5. Cripps KJ, Purdie CA, Carder PJ, White S, Komine K, Bird CC, Wyllie AH: A study of p53 protein stabilisation versus point mutation in colorectal carcinoma. Oncogene 9:2739-2743, 1994.
6. Dix B, Robbins P, Carrello S, House A, Iacopetta B: Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer 70:585-590, 1994.
7. Elledge RM: Assessing p53 status in breast cancer prognosis: Where should we put the thermometer when you think your p53 is sick? J Natl Cancer Inst 88:141-142, 1996.
8. Gannon JV, Greaves R, Iggo R, Lane DP: Activating mutations in p53 produce a common conformational effect. EMBO J 9:1595-1602, 1990.
9. Hall PA, Ray A, Lemoine NR, Midgley CA, Krausz T, Lane DP: p53 immunostaining as a marker of malignant disease in diagnostic cytopathology. Lancet 338:513-517, 1991.
10. Hall PA, Lane DP: p53 in tumour pathology: Can we trust immunohistochemistry? Revisited. J Pathol 172:1-4, 1994.
11. Hamelin R, Laurent-Puig P, Olschwang S, Jego N, Asselain B, Remvikos Y, Girodet J, Salmon RJ, Thomas G: Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 106:42-48, 1994.
12. Hammel PR, Beuvon FX, Salmon RJ, Remvikos Y: Immunochemical evidence of mutated p53 protein expressed in human colorectal cancer. Gastroenterol Clin Biol 15:529-535, 1991.
13. Ko LJ, Prives C: p53: Puzzle and paradigm. Genes Dev 10:1054-1072, 1996.
14. Lubbert M, Miller CW, Crawford L, Koeffler HP: p53 in chronic myelogenous leukemia. Study of mechanisms of differential expression. J Exp Med 167:873-876, 1988.
15. Muleris M, Delattre O, Olschwang S, Remvikos Y, Salmon RJ, Thomas G, Dutrillaux B: Cytogenetic and molecular approaches of polyploidization in colorectal adenocarcinomas. Cancer Genet Cytogenet 44:107-118, 1990.
16. Muleris M, Salmon RJ, Dutrillaux B: Cytogenetics of colorectal adenocarcinoma. Cancer Genet Cytogenet 46:143-156, 1990.
17. Remvikos Y, Laurent-Puig P, Salmong RJ, Frelat G, Dutrillaux B, Thomas G: Simultaneous monitoring of p53 protein and DNA content of colorectal adenocarcinomas by flow cytometry. Int J Cancer 45:450-456, 1990.
18. Remvikos Y, Tominaga O, Hammel P, Laurent-Puig P, Salmon RJ, Dutrillaux B, Thomas G: Increased protein content of colorectal tumors correlates with poor survival. Br J Cancer 66:758-764, 1992.
19. Remvikos Y, Vogt N, Muleris M, Salmon RJ, Malfoy B, Dutrillaux B: DNA-repeat instability is associated with colorectal cancers presenting minimal chromosomal rearrangements. Genes Chromosomes Cancer 12:272-276, 1995.
20. Remvikos Y, Muleris M, Salmon RJ, Dutrillaux B: Colorectal carcinogenesis: From chromosomal evolution pathways to molecular pathogenesis. Cancer Genet Cytogenet 93:63-73, 1997.
21. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP: p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87:7555-7559, 1990.
22. Rubio MP, Von DA, Yandell DW, Wiestler OD, Gusella JF, Louis DN: Accumulation of wild type p53 protein in human astrocytomas. Cancer Res 53:3465-3467, 1993.
23. Smith DR, Goh HS: Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinoma. Br J Cancer 74:216-223, 1996.
24. Soussi T: DNA-binding properties of the major structural protein of SV40. J Virol 59:740-742, 1986.
25. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B: Multifactorial analysis of p53 alteration in human cancer: A review. Int J Cancer 57:1-9, 1994.
26. Starzynska T, Bromley M, Ghosh A, Stern PL: Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 66:558-562, 1992.
27. Sun XF, Carsensen JM, Zhang H, Stal O, Wingren S, Hatschek T, Nordenskjold B: Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 340:1369-1373, 1992.
28. Tominaga O, Hamelin R, Trouvat V, Salmon RJ, Lesec G, Thomas G, Remvikos Y: Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomas. Oncogene 8:2653-2658, 1993.